← Browse by Condition
Medical Condition

coronary artery disease

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for coronary artery disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — coronary artery disease Clinical Trials

How many clinical trials are currently recruiting for coronary artery disease?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for coronary artery disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for coronary artery disease?
coronary artery disease research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a coronary artery disease clinical trial?
Eligibility criteria for coronary artery disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Heinrich-Heine University, Duesseldorf 1 trial
University Medical Center Groningen 1 trial
Tomsk National Research Medical Center of the Russian Academy of Sciences 1 trial
Shanghai Zhongshan Hospital 1 trial
Korea University Guro Hospital 1 trial

Recruiting Clinical Trials

NCT06599424
Recruiting

IntraRenal HEmoDynamics to IntegraTE CA-AKI Risk and Monitor NephroprotectiIoN by ImpElla Support.

Enrollment
550 pts
Location
Germany
Sponsor
Heinrich-Heine University, Due...
View Trial →
NCT07269366
Recruiting

Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)

Enrollment
358 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT07476274
Recruiting

Nosocomial Pneumonia After Coronary Artery Bypass Grafting

Enrollment
80 pts
Location
Russia
Sponsor
Tomsk National Research Medica...
View Trial →
NCT07169201
Recruiting

High-Resolution CT for Heart

Enrollment
500 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
View Trial →
NCT07198529
Recruiting

OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina

Enrollment
130 pts
Location
South Korea
Sponsor
Korea University Guro Hospital
View Trial →
NCT06258681
Recruiting

Customizable Respiratory Exercise Device in Individuals Who Have Undergone Cardiac Surgery

Enrollment
20 pts
Location
Turkey (Türkiye)
Sponsor
Biruni University
View Trial →
NCT04436978 Phase 4
Recruiting

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

Enrollment
2,000 pts
Location
Belgium, Netherlands
Sponsor
St. Antonius Hospital
View Trial →
NCT06001073
Recruiting

Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics

Enrollment
25,000 pts
Location
China
Sponsor
First Affiliated Hospital Xi'a...
View Trial →
NCT05775445
Recruiting

Extremes of Coronary Artery Disease and Normality:CAD Extremes

Enrollment
1,500 pts
Location
Singapore
Sponsor
National Heart Centre Singapor...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology